Literature DB >> 20026177

Clinical availability of skin biopsy in the diagnosis of Parkinson's disease.

Yasuo Miki1, Masahiko Tomiyama, Tatsuya Ueno, Rie Haga, Haruo Nishijima, Chieko Suzuki, Fumiaki Mori, Mitsuomi Kaimori, Masayuki Baba, Koichi Wakabayashi.   

Abstract

To determine whether skin biopsy is practically useful in the premortem diagnosis for Parkinson's disease (PD), we examined Lewy pathology in the skin of the chest wall and leg, obtained from 6-mm punch biopsies, using phosphorylated alpha-synuclein antibody in 20 patients with clinically diagnosed PD. Abnormal accumulation of alpha-synuclein was found in the chest skin of two (10%) of 20 patients, but not in the leg. Although skin biopsy combined with a conventional immunohistochemistry for alpha-synuclein is not sufficient as a diagnostic tool, we could firstly demonstrate Lewy pathology in premortem tissue. The skin remains to be a promising tissue to be examined for the premortem diagnosis of PD. (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20026177     DOI: 10.1016/j.neulet.2009.12.027

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  35 in total

Review 1.  The Lewy body in Parkinson's disease and related neurodegenerative disorders.

Authors:  Koichi Wakabayashi; Kunikazu Tanji; Saori Odagiri; Yasuo Miki; Fumiaki Mori; Hitoshi Takahashi
Journal:  Mol Neurobiol       Date:  2012-05-24       Impact factor: 5.590

Review 2.  Skin nerve α-synuclein deposits in Parkinson's disease and other synucleinopathies: a review.

Authors:  Vincenzo Donadio
Journal:  Clin Auton Res       Date:  2018-11-30       Impact factor: 4.435

3.  Alpha-Synuclein Pathology in Sensory Nerve Terminals of the Upper Aerodigestive Tract of Parkinson's Disease Patients.

Authors:  Liancai Mu; Jingming Chen; Stanislaw Sobotka; Themba Nyirenda; Brian Benson; Fiona Gupta; Ira Sanders; Charles H Adler; John N Caviness; Holly A Shill; Marwan Sabbagh; Johan E Samanta; Lucia I Sue; Thomas G Beach
Journal:  Dysphagia       Date:  2015-06-04       Impact factor: 3.438

4.  Submandibular gland needle biopsy for the diagnosis of Parkinson disease.

Authors:  Charles H Adler; Brittany N Dugger; Michael L Hinni; David G Lott; Erika Driver-Dunckley; Jose Hidalgo; Jonette Henry-Watson; Geidy Serrano; Lucia I Sue; Thomas Nagel; Amy Duffy; Holly A Shill; Haruhiko Akiyama; Douglas G Walker; Thomas G Beach
Journal:  Neurology       Date:  2014-02-05       Impact factor: 9.910

5.  The diagnostic value of minor salivary gland biopsy in clinically diagnosed patients with Parkinson's disease: comparison with DAT PET scans.

Authors:  Liyan Gao; Huimin Chen; Xin Li; Fangfei Li; Qiaohong Ou-Yang; Tao Feng
Journal:  Neurol Sci       Date:  2015-03-28       Impact factor: 3.307

Review 6.  The pathology roadmap in Parkinson disease.

Authors:  D James Surmeier; David Sulzer
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

Review 7.  Uses of skin biopsy for sensory and autonomic nerve assessment.

Authors:  M Iliza Myers; Amanda C Peltier
Journal:  Curr Neurol Neurosci Rep       Date:  2013-01       Impact factor: 5.081

8.  Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms.

Authors:  Thibaud Lebouvier; Michel Neunlist; Stanislas Bruley des Varannes; Emmanuel Coron; Anne Drouard; Jean-Michel N'Guyen; Tanguy Chaumette; Maddalena Tasselli; Sébastien Paillusson; Mathurin Flamand; Jean-Paul Galmiche; Philippe Damier; Pascal Derkinderen
Journal:  PLoS One       Date:  2010-09-14       Impact factor: 3.240

Review 9.  Is there a need to redefine Parkinson's disease?

Authors:  Philipp Mahlknecht; Werner Poewe
Journal:  J Neural Transm (Vienna)       Date:  2013-05-29       Impact factor: 3.575

10.  Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease.

Authors:  Liancai Mu; Stanislaw Sobotka; Jingming Chen; Hungxi Su; Ira Sanders; Charles H Adler; Holly A Shill; John N Caviness; Johan E Samanta; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2013-02       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.